Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Labia

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Antimicrobial Agents and Chemotherapy|July 2, 1999
Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinicaF Laurent, L Poirel, T Naas, et al.
FEMS Microbiology Letters|February 17, 2001
Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolateG Barnaud, R Labia, L Raskine, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamaseS Farzaneh, E B Chaibi, J Peduzzi, et al.
Annales De Biologie Clinique|January 1, 1983
[Study of beta-lactamase in Neisseria gonorrhoeae by a gel adaptation of the iodometric method]M Guibourdenche, E Collatz, P Courvalin, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
First isolation of CTX-M15-producing Escherichia coli from two French patientsC Neuwirth, E Siebor, M Pruneaux, et al.
FEMS Microbiology Letters|July 1, 1994
Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to beta-lactamase inhibitorsT Brun, J Péduzzi, M M Caniça, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolateC Neuwirth, R Labia, E Siebor, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1996
Problems encountered in the characterization of IRT beta-lactamase-producing clinical Escherichia coli isolates intermediate-resistant to cephalothinE B Chaibi, S Farzaneh, A Morand, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytocaH Bermudes, F Jude, E B Chaibi, et al.
Antimicrobial Agents and Chemotherapy|December 5, 1998
Inhibitor-resistant TEM beta-lactamases: revision of the TEM-41 sequenceR Labia, E B Chaibi, D Sirot, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|July 2, 1999
Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinicaF Laurent, L Poirel, T Naas, et al.
FEMS Microbiology Letters|February 17, 2001
Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolateG Barnaud, R Labia, L Raskine, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamaseS Farzaneh, E B Chaibi, J Peduzzi, et al.
Annales De Biologie Clinique|January 1, 1983
[Study of beta-lactamase in Neisseria gonorrhoeae by a gel adaptation of the iodometric method]M Guibourdenche, E Collatz, P Courvalin, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
First isolation of CTX-M15-producing Escherichia coli from two French patientsC Neuwirth, E Siebor, M Pruneaux, et al.
FEMS Microbiology Letters|July 1, 1994
Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to beta-lactamase inhibitorsT Brun, J Péduzzi, M M Caniça, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolateC Neuwirth, R Labia, E Siebor, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1996
Problems encountered in the characterization of IRT beta-lactamase-producing clinical Escherichia coli isolates intermediate-resistant to cephalothinE B Chaibi, S Farzaneh, A Morand, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytocaH Bermudes, F Jude, E B Chaibi, et al.
Antimicrobial Agents and Chemotherapy|December 5, 1998
Inhibitor-resistant TEM beta-lactamases: revision of the TEM-41 sequenceR Labia, E B Chaibi, D Sirot, et al.
Pageof 19